Endpoints launches nominations for its 2026 Women in Biopharma project

Endpoints announced that nominations are now open for its eighth annual Women in Biopharma initiative, which highlights contributions of women in the industry.

The program, scheduled for 2026, seeks nominations of individuals who have demonstrated leadership, scientific excellence, or advocacy within biopharma. Nominees will be considered for inclusion in a special project that showcases their achievements.

The call for nominations is part of Endpoints’ ongoing effort to recognize and promote gender diversity in the sector. Interested parties can submit entries through the Endpoints website, with limited free access provided for readers.